Mechanisms of the Wnt Pathways as a Potential Target Pathway in Atherosclerosis

키워드

참고문헌 (68)

1. Bhavanasi D, "Wnt signaling in normal and malignant stem cells", Curr Stem Cell Rep, 2, pp.379~387 (2016)
2. Sharma M, "Dishevelled : a masterful conductor of complex Wnt signals", Cell Signal, 47, pp.52~64 (2018)
3. Verheyen EM, "Regulation of Wnt", beta-catenin signaling by protein kinases, 2010, pp.239, 34~44
4. Wu D, "GSK3 : a multifaceted kinase in Wnt signaling", Trends Biochem Sci, 35, pp.161~168 (2010)
5. Komiya Y, "Wnt signal transduction pathways", Organogenesis, 4, pp.68~75 (2008)
6. Kohn AD, "Wnt and calcium signaling : beta-catenin-independent pathways", Cell Calcium, 38, pp.439~446 (2005)
7. MacDonald BT, "Wnt", beta-catenin signaling : components, mechanisms, and diseases, 2009, pp.17, 9~26
8. Li F, "Winding through the Wnt pathway during cellular development and demise", Histol Histopathol, 21, pp.103~124 (2006)
9. De A, "Wnt", Ca2+ signaling pathway : a brief overview, 2011, pp.43, 745~756
10. Thiel G, "Ca2+ microdomains, calcineurin and the regulation of gene transcription", Cells, 10, pp.875~ (2021)
11. Abou Ziki MD, "Wnt signaling, a novel pathway regulating blood pressure?", State of the art review. Atherosclerosis, 262, pp.171~178 (2017)
12. Go GW, "Low-density lipoprotein receptor-related protein 6(LRP6)is a novel nutritional therapeutic target for hyperlipidemia, non-alcoholic fatty liver disease, and atherosclerosis", Nutrients, 7, pp.4453~4464 (2015)
13. Christman MA 2nd, "Wnt5a is expressed in murine and human atherosclerotic lesions", Am J Physiol Heart Circ Physiol, 294, pp.H2864~H2870 (2008)
14. Kummitha CM, "A sandwich ELISA for the detection of Wnt5a", J Immunol Methods, 352, pp.38~44 (2010)
15. Weerackoon N, "Wnt signaling cascades and their role in coronary artery health and disease", J Cell Signal, 2, pp.52~62 (2021)
16. Garcia-Martín A, "Relationship of Dickkopf1(DKK1)with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus", PLoS One, 9, pp.e111703~ (2014)
17. Foulquier S, "Wnt signaling in cardiac and vascular disease", Pharmacol Rev, 70, pp.68~141 (2018)
18. Milutinović A, "Pathogenesis of atherosclerosis in the tunica intima, media, and adventitia of coronary arteries : an updated review", Bosn J Basic Med Sci, 20, pp.21~30 (2020)
19. Grootaert MO, "Vascular smooth muscle cells in atherosclerosis : time for a re-assessment", Cardiovasc Res, 117, pp.2326~2339 (2021)
20. Félétou M., "The endothelium: Part 1: Multiple functions of the endothelial cells—focus on endothelium-derived vasoactive mediators" (2011), Morgan & Claypool Life Sciences
21. Theofilis P, "Inflammatory mechanisms contributing to endothelial dysfunction", Biomedicines, 9, pp.781~ (2021)
22. Olsen JJ, "The role of Wnt signalling in angiogenesis", Clin Biochem Rev, 38, pp.131~142 (2017)
23. Masckauchán TN, "Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2", Mol Biol Cell, 17, pp.5163~5172 (2006)
24. Goodwin AM, "Wnt1 and Wnt5a affect endothelial proliferation and capillary length; Wnt2 does not", Growth Factors, 25, pp.25~32 (2007)
25. Birdsey GM, "The endothelial transcription factor ERG promotes vascular stability and growth through Wnt", β-catenin signaling, 2015, pp.32, 82~96
26. Wadey KS, "Pro-inflammatory role of Wnt", β-catenin signaling in endothelial dysfunction, 2023, pp.9, 1059124~
27. Kim DJ, "Differential expression of the Wnt and Frizzled genes in Flk1+ cells derived from mouse ES cells", Cell Biochem Funct, 26, pp.24~32 (2008)
28. Vikram A, "Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species", Arterioscler Thromb Vasc Biol, 34, pp.2301~2309 (2014)
29. Mehu M, "Inflammatory cells in atherosclerosis", Antioxidants, 11, pp.233~ (2022)
30. Shao Y, "Biological functions of macrophage-derived Wnt5a, and its roles in human diseases", Oncotarget, 7, pp.67674~67684 (2016)
31. Ma B, "Crosstalk between Wnt", β-catenin and NF-κB signaling pathway during inflammation, 2016, pp.7, 378~
32. Borrell-Pages M, "LRP5", canonical Wnt signalling and healing of ischemic myocardium, 2016, pp.111, 67~
33. Xiangdong L, "Animal models for the atherosclerosis research : a review", Protein Cell, 2, pp.189~201 (2011)
34. Bennett MR, "Vascular smooth muscle cells in atherosclerosis", Circ Res, 118, pp.692~702 (2016)
35. Martinez-Font E, "Impact of Wnt", β-catenin inhibition on cell proliferation through CDC25A downregulation in soft tissue sarcomas, 2020, pp.12, 2556~
36. Conacci-Sorrell M, "The cadherin-catenin adhesion system in signaling and cancer", J Clin Invest, 109, pp.987~991 (2002)
37. Lecarpentier Y, "Multiple targets of the canonical Wnt", β-catenin signaling in cancers, 2019, pp.9, 1248~
38. Zhang Q, "Roles and action mechanisms of Wnt4 in cell differentiation and human diseases : a review", Cell Death Dis, 7, pp.287~ (2021)
39. Gavagan M, "The scaffold protein Axin promotes signaling specificity within the Wnt pathway by suppressing competing kinase reactions", Cell Syst, 10, pp.515~525 (2020)
40. Duran J, "GSK-3β", NFAT signaling is involved in testosterone-induced cardiac myocyte hypertrophy, 2016, pp.11, e0168255~
41. Park YJ, "The role of calcium-calcineurin-NFAT signaling pathway in health and autoimmune diseases", Front Immunol, 11, pp.195~ (2020)
42. Islam MM, "Low-density lipoprotein internalization, degradation and receptor recycling along membrane contact sites", Front Cell Dev Biol, 10, pp.826379~ (2022)
43. Chistiakov DA, "Macrophage-mediated cholesterol handling in atherosclerosis", J Cell Mol Med, 20, pp.17~28 (2016)
44. Charles KN, "Functional peroxisomes are essential for efficient cholesterol sensing and synthesis", Front Cell Dev Biol, 8, pp.560266~ (2020)
45. Liu Y, "The role of Wnt signalling in development of coronary artery disease and its risk factors", Open Biol, 10, pp.200128~ (2020)
46. Fahed G, "Metabolic syndrome : updates on pathophysiology and management in 2021", Int J Mol Sci, 23, pp.786~ (2022)
47. Go GW, "The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue", Cell Metab, 19, pp.209~220 (2014)
48. Joiner DM, "LRP5 and LRP6 in development and disease", Trends Endocrinol Metab, 24, pp.31~39 (2013)
49. Wang F, "Myeloid β-catenin deficiency exacerbates atherosclerosis in low-density lipoprotein receptor-deficient mice", Arterioscler Thromb Vasc Biol, 38, pp.1468~1478 (2018)
50. Actis Dato V, "The role of low-density lipoprotein receptor-related protein 1 in lipid metabolism, glucose homeostasis and inflammation", Int J Mol Sci, 19, pp.1780~ (2018)
51. He K, "An interspecies study of lipid profiles and atherosclerosis in familial hypercholesterolemia animal models with low-density lipoprotein receptor deficiency", Am J Transl Res, 11, pp.3116~3127 (2019)
52. Xian X, "LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis", eLife, 6, pp.e29292~ (2017)
53. Kaiser K, "Wnt5a is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis", Nat Commun, 10, pp.1498~ (2019)
54. Boucher P, "atherosclerosis : gone with the Wnt?", Atherosclerosis, 301, pp.15~22 (2020)
55. Bhatt PM, "Wnt5a : a player in the pathogenesis of atherosclerosis and other inflammatory disorders", Atherosclerosis, 237, pp.155~162 (2014)
56. Qin L, "The novel role and underlying mechanism of Wnt5a in regulating cellular cholesterol accumulation", Clin Exp Pharmacol Physiol, 41, pp.671~678 (2014)
57. Azbazdar Y, "Regulation of Wnt signaling pathways at the plasma membrane and their misregulation in cancer", Front Cell Dev Biol, 9, pp.631623~ (2021)
58. Jacobo-Albavera L, "The role of the ATP-binding cassette A1(ABCA1)in human disease", Int J Mol Sci, 22, pp.1593~ (2021)
59. Zhang CJ, "Wnt5a", Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis, 2020, pp.1865, 158547~
60. Yang P, "The role of bone morphogenetic protein signaling in vascular calcification", Bone, 141, pp.115542~ (2020)
61. Cheng SL, "Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets", Diabetes, 63, pp.4326~4337 (2014)
62. Zhai Y, "MSX2 is an oncogenic downstream target of activated Wnt signaling in ovarian endometrioid adenocarcinoma", Oncogene, 30, pp.4152~4162 (2011)
63. Akoumianakis I, "Non-canonical Wnt signalling in cardiovascular disease : mechanisms and therapeutic implications", Nat Rev Cardiol, 19, pp.783~797 (2022)
64. Schindeler A, "Curative cell and gene therapy for osteogenesis imperfecta", J Bone Miner Res, 37, pp.826~836 (2022)
65. Grumolato L, "Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors", Genes Dev, 24, pp.2517~2530 (2010)
66. Zeng CM, "Frizzled receptors as potential therapeutic targets in human cancers", Int J Mol Sci, 19, pp.1543~ (2018)
67. Fan J, "Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors", Oncotarget, 8, pp.27105~27119 (2017)
68. Li J, "Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes", Diabetes, 59, pp.2033~2042 (2010)

관련 논문AI추천